Skip to main content

Advertisement

Log in

Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Chronic hepatitis C virus (HCV) viremia has been known to provoke a plethora of autoimmune syndromes referred to as extrahepatic manifestations of chronic HCV infection. Aim of the current study was to assess the prevalence of rheumatologic manifestations among Egyptians with hepatitis C infection and its’ association with cryoglobulin profile. The current research represents a cross-sectional study where patients with chronic HCV infection attending the outpatient clinic of the National Hepatology and Tropical Medicine Research Institute over a period of 1 year were interviewed. Patients with decompensated liver disease, on interferon therapy, having end-stage renal disease or coexisting viral infection like hepatitis B surface antibody positive patients were all excluded from the research. Laboratory investigations as well as serological assay including cryoglobulin profile, rheumatoid factor, antinuclear antibody, HCV-PCR were performed. Three hundred and six patients having chronic HCV infection were interviewed in this research. The overall estimated prevalence of rheumatologic manifestations in the current research was 16.39%, chronic fatigue syndrome 9.5%, sicca symptoms 8.8%, arthralgia 6.5%, fibromyalgia 1.9%, myalgia 1.3%, arthritis 0.7%, cryoglobulinemic vasculitis 0.7%, autoimmune hemolytic anemia 0.7%, thrombocytopenia 0.7%. Xerophthalmia was significantly present in male population (p = 0.04), whereas fibromyalgia, cryoglobulinemic vasculitis, arthritis, and autoimmune hemolytic anemia were significantly present in female population under study (p < 0.05). In chronic HCV genotype 4 infection, the prevalence of rheumatologic manifestations was 16.3% with chronic fatigue syndrome and sicca sysmptoms being the most common with no significant correlation to the degree of elevation of liver disease or viral load.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wasley A, Alter MJ (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20(1):1–16

    Article  CAS  PubMed  Google Scholar 

  2. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P (1999) Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment virus C. Arthritis Rheum 42:2204–2212

    Article  CAS  PubMed  Google Scholar 

  3. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, Yamamoto AM, Camproux AC, Hausfater P, Musset L, Veyssier P, Raguin G, Piette JC (2000) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore) 79:47–56

    Article  CAS  Google Scholar 

  4. Sterling RK, Bralow S (2006) Extrahepatic manifestations of hepatitis. Curr Gastroenterol Rep 8(1):53–59

    Article  PubMed  Google Scholar 

  5. Galossi A, Guarisco R, Bellis L, Puoti C (2007) Extrahepatic manifestations of chronic HCV infection. J Gastrointestin Liver Dis 16(1):65–73

    PubMed  Google Scholar 

  6. Pascual M, Perrin L, Giostra E, Schifferli JA (1990) Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 162:569–570

    CAS  PubMed  Google Scholar 

  7. Gumber SC, Chopra S (1995) Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 123:615–620

    CAS  PubMed  Google Scholar 

  8. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (2007) For the Italian Association of the Study of liver Commission on Extrahepatic Manifestations of HCV infection. Extrahepatic manifestations of hepatitis C infection: a general overview and guidelines for clinical approach. Dig Liver Dis 39:2–17

    Article  CAS  PubMed  Google Scholar 

  9. Zignego AL, Giannini C, Ferri C (2007) Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13:2467–2478

    CAS  PubMed  Google Scholar 

  10. Cheney IW, Lai VC, Zhong W, Brodhag T, Dempsey S, Lim C et al (2002) Comparative analysis of antihepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 76:1148–1154

    Article  Google Scholar 

  11. Hepatitis C: The disease. Global alert and response. World Health Organization. Online issue October, 2009

  12. Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ, Mihailova AP, Hadjiev EA, Dikova RP (2007) Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and its association with cryoglobulinemia in Bulgarian patients. Viral hepatitis. World Journal of Gastroentrol 13(48):6518–6528

    Article  Google Scholar 

  13. Lormeau C, Falgarone G, Roulot D, Boissier MC (2006) Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 73(6):633–638

    Article  PubMed  Google Scholar 

  14. Rivera J, De Degio A, Trinchet M, Monforte AG (1997) Fibromyalgia-associated hepatitis C virus infection. Br J Rheum 36(9):981–985

    Article  CAS  Google Scholar 

  15. Fadda P, La Civita L, Zignego AL, Ferri C (2002) Hepatitis C virus infection and arthritis. A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome. Reumatismo 54(4):316–323

    CAS  PubMed  Google Scholar 

  16. Gisbert JP, Garca-Buey L, Pajares JM, Moreno-Otero R (2003) Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systemic review and meta-analysis. Gastroenterology 125:1723

    Article  PubMed  Google Scholar 

  17. Agnello V, De Rosa FG (2004) Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 40:341–352

    Article  PubMed  Google Scholar 

  18. Antonelli A, Ferri C, Pampana A et al (2004) Thyroid disorders in chronic hepatitis C. Am J Med 117:10

    Article  CAS  PubMed  Google Scholar 

  19. Mohamed MK, Bakr I, El-Hoseiny M, Arafa N, Hassan A, Ismail S et al (2006) HCV-related morbidity in a rural community in Egypt. J Med Virol 78(9):1185–1189

    Article  PubMed  Google Scholar 

  20. Egypt: 5 million infected by hepatitis C. Online article by the Egyptian National Hepatitis Committee, Feb: 2007. Integrated Regional Information Networks IRIN

  21. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout Egypt. J infect Diseas 182(3):698–707, Epub 2000 Aug 17

    Article  CAS  Google Scholar 

  22. Larsen A (1974) A radiological method for grading the severity of rheumatoid arthritis. Academic dissertation, University of Helsinki, Helsinki

  23. McMurray RW, Elbourne K (1997) Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 26(4):689–701

    Article  CAS  PubMed  Google Scholar 

  24. Hadziyannis SJ (1997) The spectrum of extrahepatic manifestations in hepatitis C infection. J Viral Hepat 4:9–24

    Article  CAS  PubMed  Google Scholar 

  25. Sene D, Saadoun D, Limal N, Piette JC, Cacoub P (2007) Update in hepatitis C virus associated extrahepatic manifestations. Rev Méd Interne 28:388–393

    Article  CAS  PubMed  Google Scholar 

  26. Ramos-Casals M, Muñoz S, Medina F, Jara LJ, Rosas J, Calvo-Alen J, Brito-Zerón P, Forns X, Sánchez-Tapias JM, HISPAMEC Study Group (2009) Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry). J Rheumatol 36(7):1442–1448, Epub 2009 Apr 15

    Article  PubMed  Google Scholar 

  27. Ramos-Casals M, Loustaud-Ratti V, De Vita S, Zeher M, Bosch JA, Toussirot E, Medina F, Rosas J, Anaya JM, Font J, SS-HCV Study Group (2005) Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 84:81–89

    Article  Google Scholar 

  28. Zaltron S, Puoti M, Liberini P, Antonini L, Quinzanini M, Manni M, Forleo MA, Rossi S, Spinetti A, Zanini B, Carosi G (1998) High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia. Ital J Gastroenterol Hepatol 30:391–395

    CAS  PubMed  Google Scholar 

  29. Migliaresi S, Di Iorio G, Ammendola A, Ambrosone L, Sanges G, Ugolini G, Sampaolo S, Bravaccio F, Tirri G (2001) Peripheal nervous system involvement in HCV-related mixed cryoglobulinemia. Reumatismo 53:26–32

    PubMed  Google Scholar 

  30. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M (1996) Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 24:135–140

    Article  CAS  PubMed  Google Scholar 

  31. Doi T, Homma H, Mezawa S, Kato J, Kogawa K, Sakamaki S, Niitsu Y (2002) Mechanisms for increment of platelet-associated IgG and platelet surface IgG and their implications in immune thrombocytopenia associated with chronic viral liver disease. Hepatol Res 24:23

    Article  CAS  PubMed  Google Scholar 

  32. Iga D, Tomimatsu M, Endo H, Ohkawa S, Yamada O (2005) Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia. Eur J Haematol 75:417–423

    Article  CAS  PubMed  Google Scholar 

  33. Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN (2007) Hepatitis C, cryoglobulinemia, and beyond. Rheumatology (oxford) 46:572–578, no 28

    Google Scholar 

  34. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL (1995) High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613–619

    CAS  PubMed  Google Scholar 

  35. Lamprecht P, Ahmadi-Simab K, Gross WL, Hellmich B (2006) Part 3. Research news concerning epidemiology, diagnosis, and therapy of primary systemic vasculitides. Med Klin (Munich) 101:212–225

    Article  Google Scholar 

  36. Wu YY, Hsu TC, Chen TY, Liu TC, Liu GY, Lee YJ, Tsay GJ (2002) Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol 128:347–352

    Article  CAS  PubMed  Google Scholar 

  37. Lamprecht P, Gutzeit O, Csernok E, Gause A, Longombardo G, Zignego AL, Gross WL, Ferri C (2003) Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infection. Clin Exp Rheumatol 21:S89–S94

    CAS  PubMed  Google Scholar 

  38. Buskila D, Shnaider A, Neumann L et al (1998) Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus-infected Israeli patients. Semin Arthritis Rheum 28:107–113

    Article  CAS  PubMed  Google Scholar 

  39. Pawlotsky JM, Roudot-Thoraval F, Simmonds P et al (1995) Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 122:169–173

    CAS  PubMed  Google Scholar 

  40. Clifford BD, Donahue D, Smith L et al (1995) High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613–619

    CAS  PubMed  Google Scholar 

Download references

Acknowledgment

To the National Hepatology and Tropical Medicine Institute, Cairo, Egypt for giving us the ample support and facilities to achieve the study requirements.

Disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reem Hamdy Abdellatif Mohammed.

Additional information

Funding Agency

The research was funded by the Sustained Search Institute (SSI).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohammed, R.H.A., ElMakhzangy, H.I., Gamal, A. et al. Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians. Clin Rheumatol 29, 1373–1380 (2010). https://doi.org/10.1007/s10067-010-1463-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1463-x

Keywords

Navigation